Aktiesnakken — Januar 2012
-
Jeg lover dig at hvis genmab trækker en milliard i royalties så logger den i 200
-
Det er en analyse med mange ubekendte. En af dem. Gsk er holdt op med at forære stoffet væk er det godt eller skidt?
-
Jo vi runder 100 mill iår. Vi skal gerne noget højere op
-
Ja 80
-
Det gik godt for VELO idag højeste luk siden august
-
Biotek ser ud til at være i stigende kurs i 2012
-
Hvornår kommer velo med nyt
-
De skal vel ud i den emission?
-
nej de satser på partner her i foråret
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind